pLKO.1puro-shKIBRA-A Citations (1)

Originally described in: KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S, Chang N, Sims AH, Tilston-Lunel AM, Angus L, Steele A, Boswell V, Barnett SC, Ormandy C, Faratian D, Gunn-Moore FJ, Reynolds PA Oncogene. 2012 May 21. doi: 10.1038/onc.2012.196. PubMed Journal

---

Articles Citing pLKO.1puro-shKIBRA-A

Articles
KIBRA attains oncogenic activity by repressing RASSF1A. Anuj, Arivazhagan L, Surabhi RP, Kanakarajan A, Sundaram S, Pitani RS, Mudduwa L, Kremerskothen J, Venkatraman G, Rayala SK. Br J Cancer. 2017 Jun 29. pii: bjc2017192. doi: 10.1038/bjc.2017.192. PubMed

If you have published an article using this material, please email us at to have your article added to this page.